(Q40657873)

English

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial

scientific article published on February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial (English)

1 reference

Europe PubMed Central

22 September 2017

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

Pierre-Alain Clavien

2

object named as

Pierre-Alain Clavien

1 reference

Europe PubMed Central

22 September 2017

1

object named as

Peter Neuhaus

1 reference

Europe PubMed Central

22 September 2017

5

object named as

Antoni Rimola

1 reference

Europe PubMed Central

22 September 2017

author name string

Dilip Kittur

3

1 reference

Europe PubMed Central

22 September 2017

Mauro Salizzoni

4

1 reference

Europe PubMed Central

22 September 2017

Kamal Abeywickrama

6

1 reference

Europe PubMed Central

22 September 2017

Elke Ortmann

7

1 reference

Europe PubMed Central

22 September 2017

Lawrence Chodoff

8

1 reference

Europe PubMed Central

22 September 2017

Michael Hall

9

1 reference

Europe PubMed Central

22 September 2017

Alexander Korn

10

1 reference

Europe PubMed Central

22 September 2017

Björn Nashan

11

1 reference

Europe PubMed Central

22 September 2017

CHIC 304 International Liver Study Group

12

1 reference

Europe PubMed Central

22 September 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

22 September 2017

Liver Transplantation

1 reference

Europe PubMed Central

22 September 2017

8

1 reference

Europe PubMed Central

22 September 2017

2

1 reference

Europe PubMed Central

22 September 2017

132-142

1 reference

Europe PubMed Central

22 September 2017

A longitudinal analysis of hepatitis C virus replication following liver transplantation

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.30302

21 January 2018

Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.30302

21 January 2018

A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.30302

21 January 2018

Disposition and immunodynamics of basiliximab in liver allograft recipients

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.30302

21 January 2018

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.30302

21 January 2018

Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.30302

21 January 2018

Identifiers

10.1053/JLTS.2002.30302

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40657873&oldid=2087580298"